| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9343(99)80057-6 |
| P698 | PubMed publication ID | 7825639 |
| P2093 | author name string | A Dunaif | |
| P2860 | cites work | Signal transduction by receptors with tyrosine kinase activity | Q27860624 |
| Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein | Q28116980 | ||
| The function of GRB2 in linking the insulin receptor to Ras signaling pathways | Q28259867 | ||
| Binding of the Ras activator son of sevenless to insulin receptor substrate-1 signaling complexes | Q30194979 | ||
| Mapping Diabetes-Susceptibility Genes: Lessons Learned From Search for DNA Marker for Maturity-Onset Diabetes of the Young | Q36216103 | ||
| Interplay between insulin signalling and protein kinase C. | Q37300882 | ||
| Insulin resistance with acanthosis nigricans: the roles of obesity and androgen excess | Q38351252 | ||
| The insulin receptor and its substrate: molecular determinants of early events in insulin action. | Q40485215 | ||
| Hyperinsulinemia is associated with menstrual irregularity and altered serum androgens in Pima Indian women. | Q40669866 | ||
| Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: candidates for a signal transmitter defect causing insulin resistance of the skeletal muscle | Q40852707 | ||
| The new elements of insulin signaling. Insulin receptor substrate-1 and proteins with SH2 domains | Q40853423 | ||
| Opposing actions of dehydroepiandrosterone and testosterone on insulin sensitivity. In vivo and in vitro studies of hyperandrogenic females | Q41152334 | ||
| Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome | Q42497234 | ||
| Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia | Q42517167 | ||
| Evidence for insulin resistance in nonobese patients with polycystic ovarian disease | Q44534969 | ||
| Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. | Q44788399 | ||
| The relationship of insulin insensitivity to menstrual pattern in women with hyperandrogenism and polycystic ovaries. | Q51599304 | ||
| Acanthosis Nigricans, insulin action, and hyperandrogenism: clinical, histological, and biochemical findings. | Q51609532 | ||
| Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents. | Q51613168 | ||
| Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes. | Q51639294 | ||
| Absence of insulin receptor gene mutations in three insulin-resistant women with the polycystic ovary syndrome. | Q53814172 | ||
| Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome | Q67555170 | ||
| Insulin action in non-insulin-dependent diabetes mellitus: the relationship between hepatic and extrahepatic insulin resistance and obesity | Q68197320 | ||
| Diabetes in identical twins. A study of 200 pairs | Q70659026 | ||
| Evidence for the Importance of Peripheral Tissue Events in the Development of Hirsutism in Polycystic Ovary Syndrome* | Q72788023 | ||
| Evidence for a single gene effect causing polycystic ovaries and male pattern baldness | Q72839906 | ||
| P433 | issue | 1A | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 33S-39S | |
| P577 | publication date | 1995-01-01 | |
| P1433 | published in | American Journal of Medicine | Q2842959 |
| P1476 | title | Hyperandrogenic anovulation (PCOS): a unique disorder of insulin action associated with an increased risk of non-insulin-dependent diabetes mellitus | |
| P478 | volume | 98 |
| Q35992640 | A paradigm for finding genes for a complex human trait: polycystic ovary syndrome and follistatin |
| Q37214728 | Adolescents with Classical Polycystic Ovary Syndrome Have Alterations in the Surrogate Markers of Cardiovascular Disease but Not in the Endothelial Function. The Possible Benefits of Metformin. |
| Q41550093 | Amenorrhoea |
| Q34648316 | Androgen biosynthesis from cholesterol to DHEA. |
| Q37383118 | Androgens stimulate early stages of follicular growth in the primate ovary |
| Q43156471 | Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome |
| Q42446085 | Assessment of cardiovascular autonomic function in patients with polycystic ovary syndrome |
| Q37133808 | Association of obesity and overweight with the prevalence of insulin resistance, pre-diabetes and clinical-biochemical characteristics among infertile Mexican women with polycystic ovary syndrome: a cross-sectional study |
| Q42459575 | Association of sympathovagal imbalance with cardiovascular risks in patients with polycystic ovary syndrome |
| Q57414617 | Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians |
| Q51581819 | Can metformin reduce insulin resistance in polycystic ovary syndrome? |
| Q36013142 | Cardiometabolic aspects of polycystic ovarian syndrome. |
| Q39593191 | Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study |
| Q34212172 | Cardiovascular risk in women with polycystic ovary syndrome. |
| Q44118719 | Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: is there a difference? |
| Q36263860 | Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome |
| Q44689102 | Do polycystic-appearing ovaries affect the risk of cardiovascular disease among women with polycystic ovary syndrome? |
| Q44104324 | Early steps in androgen biosynthesis: from cholesterol to DHEA. |
| Q45217868 | Effect of rosiglitazone on endocrine, metabolism and ovulatory performance in patients with polycystic ovary syndrome and insulin resistance |
| Q51565210 | Effect of troglitazone on endocrine and ovulatory performance in women with insulin resistance-related polycystic ovary syndrome. |
| Q46869085 | Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome--a randomized placebo-controlled trial. |
| Q28078717 | Effects of hyperandrogenism on metabolic abnormalities in patients with polycystic ovary syndrome: a meta-analysis |
| Q94463910 | Effects of low-dose metformin in Japanese women with clomiphene-resistant polycystic ovary syndrome |
| Q92325270 | Evolutionary origins of polycystic ovary syndrome: An environmental mismatch disorder |
| Q34013754 | Gender differences in insulin resistance, body composition, and energy balance |
| Q33559796 | Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes |
| Q79238454 | Heart rate variability in young women with polycystic ovary syndrome |
| Q28144779 | Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma |
| Q51837879 | IgG, IgA and IgM antibodies against FSH: serological markers of pathogenic autoimmunity or of normal immunoregulation? |
| Q36739203 | Indices of low-grade inflammation in polycystic ovary syndrome |
| Q34480793 | Insulin resistance and fertility in polycystic ovary syndrome |
| Q81065477 | Insulin resistance, premature adrenarche, and a risk of the Polycystic Ovary Syndrome (PCOS) |
| Q46529410 | Insulin responses to the oral glucose tolerance test in women of different ethnicity with polycystic ovary syndrome |
| Q35564923 | Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome |
| Q36812747 | Is there an independent effect of polycystic ovary syndrome (PCOS) and menopause on the prevalence of subclinical atherosclerosis in middle aged women? |
| Q46135692 | Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome |
| Q43586000 | Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters |
| Q35228206 | Long menstrual cycle is associated with type 2 diabetes mellitus in korean women |
| Q34011105 | Long-term effect of metformin on metabolic parameters in the polycystic ovary syndrome. |
| Q38937689 | Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study |
| Q51737343 | Metformin improves ovarian follicle dynamics by reducing theca cell proliferation and CYP-17 expression in an androgenized rat model. |
| Q77656494 | Molecular medicine of steroid hormone biosynthesis |
| Q41227904 | Nutrition, hormones, and breast cancer: is insulin the missing link? |
| Q42458796 | Parametrial adipose tissue and metabolic dysfunctions induced by fructose-rich diet in normal and neonatal-androgenized adult female rats |
| Q41455260 | Pathophysiology, genetics, and treatment of hyperandrogenism |
| Q26752564 | Poly Cystic Ovarian Syndrome: An Updated Overview |
| Q34345051 | Polycystic ovarian syndrome in women with epilepsy: a review |
| Q74044133 | Polycystic ovary syndrome |
| Q77919875 | Polycystic ovary syndrome |
| Q35692892 | Polycystic ovary syndrome: a review for primary providers |
| Q36872445 | Recent progress in the use of genetics to understand links between type 2 diabetes and related metabolic traits |
| Q40867121 | Relationship between hyperandrogenism, obesity, inflammation and polycystic ovary syndrome. |
| Q43723378 | Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. |
| Q46180967 | Reproductive history and risk of type 2 diabetes mellitus in postmenopausal women: findings from the Women's Health Initiative |
| Q27693908 | Review on autoimmune reactions in female infertility: antibodies to follicle stimulating hormone |
| Q50877420 | Role of phyto-oestrogens in ovulation induction in women with polycystic ovarian syndrome. |
| Q28284145 | Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome |
| Q46347674 | Serum leptin as an additional possible pathogenic factor in polycystic ovary syndrome |
| Q26999869 | Sex dimorphism and depot differences in adipose tissue function |
| Q36533814 | Symptoms and treatments of polycystic ovary syndrome |
| Q35608887 | The pathophysiology of polycystic ovary syndrome |
| Q34163132 | The polycystic ovary syndrome: treatment with insulin sensitizing agents |
| Q51553418 | The prevalence of polycystic ovaries in women with a history of gestational diabetes. |
| Q77690932 | Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications |
| Q53862512 | [Micropolycystic ovaries and insulin-resistance syndrome]. |
Search more.